The Surge of Biosimilars and Healthcare Accessibility in the China...

ha aggiunto un file Health

2026-04-02 12:10:05 -

The Surge of Biosimilars and Healthcare Accessibility in the China Biopharmaceuticals Market

The fight for affordable chronic disease management is being won through biological engineering this year. In 2026, the China Biopharmaceuticals Market is seeing a massive acceleration in the biosimilars segment, which is expected to grow at an extraordinary CAGR of over 20 percent through 2033. With major biologic patents expiring globally, Chinese manufacturers have rapidly scaled production...

0 Commenti 0 condivisioni 285 Views 0 Anteprima

Install Ework Face